COhort to study BLAdder CancEr (COBLAnCE)
COBLAnCE is a French national prospective cohort of patients with bladder cancer. A total of 1,800 patients aged 18 years or above, who were due to undergo transurethral resection of a bladder tumour (TURBT) or cystectomy at 1 of the 14 participating centres, were enrolled in the cohort between November 2012 and June 2018, and will be followed for 6 years. Data on patient and tumour characteristics, treatments, outcomes, and biological samples are collected at enrolment and during the follow-up.
Study design
Cohort - clinical
Number of participants at first data collection
1,800 (participants)
Age at first data collection
≥ 18 years (participants)
Participant year of birth
Varied (participants)
Participant sex
All
Representative sample at baseline?
No
Sample features
Country
Year of first data collection
2012
Primary Institutions
National Institute of Health and Medical Research (Institut National de la Santé et de la Recherche Médicale, INSERM)
Profile paper DOI
Funders
French League against Cancer (Ligue Nationale Contre le Cancer, LNCC)
French National Research Agency (ANR)
Ongoing?
No
Data types collected
- Interview – face-to-face
- Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
- Secondary data
- Self-report questionnaire – paper or computer assisted
- None
- None
- Healthcare data
Engagement
Keywords
